Global Gene Knockdown Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201100639 | Category: Service & Software | Pages: 111 | Format: PDF | Published Date: June 13,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Gene Knockdown market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gene Knockdown market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Medical accounting for  % of the Gene Knockdown global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While siRNA segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Gene Knockdown include Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), and Agilent Technologies (US), etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Gene Knockdown market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    siRNA
    shRNA
    Other
Market segment by Application, can be divided into
    Medical
    Bioengineering
    Other
Market segment by players, this report covers
    Santa Cruz Biotechnology (US)
    OriGene (US)
    Sigma-Aldrich (US)
    Abnova (Taiwan)
    Agilent Technologies (US)
    Bio-Rad (US)
    Cell Signaling Technology (US)
    GeneCopoeia (US)
    siTOOLs Biotech (Germany)
    Novus Biologicals (US)
    EMD Millipore (US)
    BioVision (US)
    Creative Biomart (US)
    Selleck Chemicals (US)
    MyBioSource (US)
    Invitrogen (US)
    Qiagen (Germany)
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Knockdown product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Knockdown, with revenue, gross margin and global market share of Gene Knockdown from 2019 to 2022.
Chapter 3, the Gene Knockdown competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene Knockdown market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene Knockdown research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Gene Knockdown
    1.2 Classification of Gene Knockdown by Type
        1.2.1 Overview: Global Gene Knockdown Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Gene Knockdown Revenue Market Share by Type in 2021
        1.2.3 siRNA
        1.2.4 shRNA
        1.2.5 Other
    1.3 Global Gene Knockdown Market by Application
        1.3.1 Overview: Global Gene Knockdown Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Medical
        1.3.3 Bioengineering
        1.3.4 Other
    1.4 Global Gene Knockdown Market Size & Forecast
    1.5 Global Gene Knockdown Market Size and Forecast by Region
        1.5.1 Global Gene Knockdown Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Gene Knockdown Market Size by Region, (2017-2022)
        1.5.3 North America Gene Knockdown Market Size and Prospect (2017-2028)
        1.5.4 Europe Gene Knockdown Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Gene Knockdown Market Size and Prospect (2017-2028)
        1.5.6 South America Gene Knockdown Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Gene Knockdown Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gene Knockdown Market Drivers
        1.6.2 Gene Knockdown Market Restraints
        1.6.3 Gene Knockdown Trends Analysis
2 Company Profiles
    2.1 Santa Cruz Biotechnology (US)
        2.1.1 Santa Cruz Biotechnology (US) Details
        2.1.2 Santa Cruz Biotechnology (US) Major Business
        2.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Product and Solutions
        2.1.4 Santa Cruz Biotechnology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Santa Cruz Biotechnology (US) Recent Developments and Future Plans
    2.2 OriGene (US)
        2.2.1 OriGene (US) Details
        2.2.2 OriGene (US) Major Business
        2.2.3 OriGene (US) Gene Knockdown Product and Solutions
        2.2.4 OriGene (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 OriGene (US) Recent Developments and Future Plans
    2.3 Sigma-Aldrich (US)
        2.3.1 Sigma-Aldrich (US) Details
        2.3.2 Sigma-Aldrich (US) Major Business
        2.3.3 Sigma-Aldrich (US) Gene Knockdown Product and Solutions
        2.3.4 Sigma-Aldrich (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Sigma-Aldrich (US) Recent Developments and Future Plans
    2.4 Abnova (Taiwan)
        2.4.1 Abnova (Taiwan) Details
        2.4.2 Abnova (Taiwan) Major Business
        2.4.3 Abnova (Taiwan) Gene Knockdown Product and Solutions
        2.4.4 Abnova (Taiwan) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Abnova (Taiwan) Recent Developments and Future Plans
    2.5 Agilent Technologies (US)
        2.5.1 Agilent Technologies (US) Details
        2.5.2 Agilent Technologies (US) Major Business
        2.5.3 Agilent Technologies (US) Gene Knockdown Product and Solutions
        2.5.4 Agilent Technologies (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Agilent Technologies (US) Recent Developments and Future Plans
    2.6 Bio-Rad (US)
        2.6.1 Bio-Rad (US) Details
        2.6.2 Bio-Rad (US) Major Business
        2.6.3 Bio-Rad (US) Gene Knockdown Product and Solutions
        2.6.4 Bio-Rad (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Bio-Rad (US) Recent Developments and Future Plans
    2.7 Cell Signaling Technology (US)
        2.7.1 Cell Signaling Technology (US) Details
        2.7.2 Cell Signaling Technology (US) Major Business
        2.7.3 Cell Signaling Technology (US) Gene Knockdown Product and Solutions
        2.7.4 Cell Signaling Technology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Cell Signaling Technology (US) Recent Developments and Future Plans
    2.8 GeneCopoeia (US)
        2.8.1 GeneCopoeia (US) Details
        2.8.2 GeneCopoeia (US) Major Business
        2.8.3 GeneCopoeia (US) Gene Knockdown Product and Solutions
        2.8.4 GeneCopoeia (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 GeneCopoeia (US) Recent Developments and Future Plans
    2.9 siTOOLs Biotech (Germany)
        2.9.1 siTOOLs Biotech (Germany) Details
        2.9.2 siTOOLs Biotech (Germany) Major Business
        2.9.3 siTOOLs Biotech (Germany) Gene Knockdown Product and Solutions
        2.9.4 siTOOLs Biotech (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 siTOOLs Biotech (Germany) Recent Developments and Future Plans
    2.10 Novus Biologicals (US) 
        2.10.1 Novus Biologicals (US) Details
        2.10.2 Novus Biologicals (US) Major Business
        2.10.3 Novus Biologicals (US) Gene Knockdown Product and Solutions
        2.10.4 Novus Biologicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Novus Biologicals (US) Recent Developments and Future Plans
    2.11 EMD Millipore (US)
        2.11.1 EMD Millipore (US) Details
        2.11.2 EMD Millipore (US) Major Business
        2.11.3 EMD Millipore (US) Gene Knockdown Product and Solutions
        2.11.4 EMD Millipore (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 EMD Millipore (US) Recent Developments and Future Plans
    2.12 BioVision (US)
        2.12.1 BioVision (US) Details
        2.12.2 BioVision (US) Major Business
        2.12.3 BioVision (US) Gene Knockdown Product and Solutions
        2.12.4 BioVision (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 BioVision (US) Recent Developments and Future Plans
    2.13 Creative Biomart (US)
        2.13.1 Creative Biomart (US) Details
        2.13.2 Creative Biomart (US) Major Business
        2.13.3 Creative Biomart (US) Gene Knockdown Product and Solutions
        2.13.4 Creative Biomart (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Creative Biomart (US) Recent Developments and Future Plans
    2.14 Selleck Chemicals (US)
        2.14.1 Selleck Chemicals (US) Details
        2.14.2 Selleck Chemicals (US) Major Business
        2.14.3 Selleck Chemicals (US) Gene Knockdown Product and Solutions
        2.14.4 Selleck Chemicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Selleck Chemicals (US) Recent Developments and Future Plans
    2.15 MyBioSource (US)
        2.15.1 MyBioSource (US) Details
        2.15.2 MyBioSource (US) Major Business
        2.15.3 MyBioSource (US) Gene Knockdown Product and Solutions
        2.15.4 MyBioSource (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 MyBioSource (US) Recent Developments and Future Plans
    2.16 Invitrogen (US)
        2.16.1 Invitrogen (US) Details
        2.16.2 Invitrogen (US) Major Business
        2.16.3 Invitrogen (US) Gene Knockdown Product and Solutions
        2.16.4 Invitrogen (US) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Invitrogen (US) Recent Developments and Future Plans
    2.17 Qiagen (Germany)
        2.17.1 Qiagen (Germany) Details
        2.17.2 Qiagen (Germany) Major Business
        2.17.3 Qiagen (Germany) Gene Knockdown Product and Solutions
        2.17.4 Qiagen (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Qiagen (Germany) Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Gene Knockdown Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Gene Knockdown Players Market Share in 2021
        3.2.2 Top 10 Gene Knockdown Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Gene Knockdown Players Head Office, Products and Services Provided
    3.4 Gene Knockdown Mergers & Acquisitions
    3.5 Gene Knockdown New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Gene Knockdown Revenue and Market Share by Type (2017-2022)
    4.2 Global Gene Knockdown Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Gene Knockdown Revenue Market Share by Application (2017-2022)
    5.2 Global Gene Knockdown Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Gene Knockdown Revenue by Type (2017-2028)
    6.2 North America Gene Knockdown Revenue by Application (2017-2028)
    6.3 North America Gene Knockdown Market Size by Country
        6.3.1 North America Gene Knockdown Revenue by Country (2017-2028)
        6.3.2 United States Gene Knockdown Market Size and Forecast (2017-2028)
        6.3.3 Canada Gene Knockdown Market Size and Forecast (2017-2028)
        6.3.4 Mexico Gene Knockdown Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Gene Knockdown Revenue by Type (2017-2028)
    7.2 Europe Gene Knockdown Revenue by Application (2017-2028)
    7.3 Europe Gene Knockdown Market Size by Country
        7.3.1 Europe Gene Knockdown Revenue by Country (2017-2028)
        7.3.2 Germany Gene Knockdown Market Size and Forecast (2017-2028)
        7.3.3 France Gene Knockdown Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Gene Knockdown Market Size and Forecast (2017-2028)
        7.3.5 Russia Gene Knockdown Market Size and Forecast (2017-2028)
        7.3.6 Italy Gene Knockdown Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Gene Knockdown Revenue by Type (2017-2028)
    8.2 Asia-Pacific Gene Knockdown Revenue by Application (2017-2028)
    8.3 Asia-Pacific Gene Knockdown Market Size by Region
        8.3.1 Asia-Pacific Gene Knockdown Revenue by Region (2017-2028)
        8.3.2 China Gene Knockdown Market Size and Forecast (2017-2028)
        8.3.3 Japan Gene Knockdown Market Size and Forecast (2017-2028)
        8.3.4 South Korea Gene Knockdown Market Size and Forecast (2017-2028)
        8.3.5 India Gene Knockdown Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Gene Knockdown Market Size and Forecast (2017-2028)
        8.3.7 Australia Gene Knockdown Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Gene Knockdown Revenue by Type (2017-2028)
    9.2 South America Gene Knockdown Revenue by Application (2017-2028)
    9.3 South America Gene Knockdown Market Size by Country
        9.3.1 South America Gene Knockdown Revenue by Country (2017-2028)
        9.3.2 Brazil Gene Knockdown Market Size and Forecast (2017-2028)
        9.3.3 Argentina Gene Knockdown Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Gene Knockdown Revenue by Type (2017-2028)
    10.2 Middle East & Africa Gene Knockdown Revenue by Application (2017-2028)
    10.3 Middle East & Africa Gene Knockdown Market Size by Country
        10.3.1 Middle East & Africa Gene Knockdown Revenue by Country (2017-2028)
        10.3.2 Turkey Gene Knockdown Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Gene Knockdown Market Size and Forecast (2017-2028)
        10.3.4 UAE Gene Knockdown Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Gene Knockdown Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?